Kelyniam Global receives prototype order to make Custom Cranial Implants

Kelyniam Global, Inc. (PINKSHEETS: KLYG) announces today that the company has received a prototype order from a California distributor to make Custom Cranial Implants.

Kelyniam received the CT (computerized tomography) data late Friday, and will have the prototypes cut and shipped on Tuesday along with a host bone stereolithography model and inspection data provided by laser scanning. More information about Kelyniam's ability to provide Custom Cranial Implants can be found by following the link from a previous press release IMPLANT-PRESS-RELEASE.

Mr. James Ketner, Kelyniam Global, Inc. founder, stated: "We believe this is the beginning of a successful relationship that will allow us to utilize our extensive CADCAM experience to aid and assist the medical disciplines. After the successful completion of the prototype models, we are hoping to cut some actual implants from FDA approved polymers later on this week."

Kelyniam also announced today the negotiations between PerioSeal Inc. and Kelyniam have been terminated. A mutual agreement could not be met regarding the acquisitions that would be equitable to either PerioSeal, Inc. or the shareholders of Kelyniam, and both parties have agreed to terminate the negotiations.

Kelyniam is currently pursuing other acquisitions as well as promoting the company's ability to manufacture custom bone implants using FDA approved polymers.

Kelyniam Global, Inc. recently created a new video describing some of the company's new and exciting technology. The video can be watched by going to the company website and selecting the video icon on the left-hand side of the website. www.kelyniam.com

SOURCE: Kelyniam Global, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Clec14a protein found to play vital role in regulating bone formation and density